用mizoprostol实施门诊分娩诱导的临床结果和可行性:一个前性队列研究
Kjersti Engen Marsdal1,2, Ingvil Krarup Sørbye1,3, Stine Bernitz2,4
1Division of Obstetrics and Gynecology, Oslo University Hospital, Oslo, Norway.
Acta obstetricia et gynecologica Scandinavica
|January 29, 2025
概括
使用口服mizoprostol的门诊诱导分娩 (IOL) 是安全的和可行的,结果与住院IOL相似. 门诊组的患者在出生前住院时间较短.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 生殖健康 生殖健康
背景情况:
- 劳动诱导率的上升需要探索高效和以患者为中心的方法.
- 门诊引产 (IOL) 在患者满意度,成本降低和资源管理方面提供了潜在的好处.
- 口服mizoprostol正在作为门诊IOL的方法获得吸引力,特别是在北欧国家.
研究的目的:
- 为了评估室外患者使用口服mizoprostol IOL 的临床结果.
- 评估实施口服mizoprostol的门诊IOL协议的可行性.
- 为了比较门诊和住院IOL组之间的安全性和有效性终点.
主要方法:
- 一个多中心的前性队列研究 (LINO项目),涉及212名低风险怀孕的妇女.
- 使用口服mizoprostol的门诊患者和住院患者的IOL的比较.
- 主要结局:入院前或30分钟内分娩;次要结局:对母亲和新生儿的安全性和有效性.
主要成果:
- 门诊和住院患者组之间的不良事件或安全结果没有显著差异.
- 门诊组从入院到分娩的时间明显缩短 (12.3小时 vs 28.1小时).
- 门诊组中的76.4%的女性在家中完成了mizoprostol治疗.
结论:
- 室外患者使用口服mizoprostol的内腔镜的安全性与住院患者的内腔镜相提并论.
- 门诊IOL导致住院时间缩短,提高了效率.
- 口服mizoprostol似乎是门诊IOL协议的安全和可行的选择,需要进一步调查.
相关概念视频
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
46
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
46
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
333
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
333


